Comparison of the efficacy of 9 weeks versus 52 weeks of adjuvant trastuzumab treatment in HER 2 positive early stage breast cancer with axillary lymph node metastases

ŞENDUR M. A. N., ÖZDEMİR N., Ozatlı T., YAZICI O., Ekinci A. S., Yazılıtas D., ...More

39th Esmo Congress, 26 - 30 September 2014

• Publication Type: Conference Paper
• Gazi University Affiliated: No